Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-23-011630
Filing Date
2023-04-28
Accepted
2023-04-28 16:15:32
Documents
8
Period of Report
2023-05-25

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A pbla20230428_def14a.htm DEF 14A 552328
2 image01.jpg GRAPHIC 15225
3 pic5.jpg GRAPHIC 37727
4 pic6.jpg GRAPHIC 36836
5 proxy1.jpg GRAPHIC 153221
6 proxy2.jpg GRAPHIC 90857
7 proxy3.jpg GRAPHIC 118805
8 proxy4.jpg GRAPHIC 111832
  Complete submission text file 0001437749-23-011630.txt   1331463
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39468 | Film No.: 23866406
SIC: 2834 Pharmaceutical Preparations